Mesa Laboratories
MLAB
88 hedge funds and large institutions have $297M invested in Mesa Laboratories in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
22% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 27
2% more funds holding
Funds holding: 86 → 88 (+2)
1% more ownership
Funds ownership: 64.46% → 65.46% (+1%)
2% more capital invested
Capital invested by funds: $291M → $297M (+$6.02M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| 1 |
BlackRock
New York
|
+$19.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.72M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$5.05M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.29M |
| 5 |
RA
Royce & Associates
New York
|
+$1.2M |
Top Sellers
MLAB Hedge Fund Activity: Q1 2017 in Review
88 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q1 2017, worth a combined $297M — up 2.1% from $291M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MLAB positions and 1 closed out — a net gain of 7 holders — while 33 added to existing stakes and 27 trimmed.
The largest buyer was BlackRock, adding an estimated $19.4M. The largest seller was Nine Ten Capital Management, cutting an estimated $3.48M.
- 88 institutional investors held Mesa Laboratories (MLAB) as of Q1 2017, up from 86 in Q4 2016.
- Funds reported $297M of Mesa Laboratories stock for Q1 2017, up 2.1% quarter-over-quarter.
- 8 funds opened new Mesa Laboratories positions in Q1 2017 and 1 closed out, a net change of +7 holders.
- The largest Mesa Laboratories buyer in Q1 2017 was BlackRock, an estimated $19.4M added.
- The largest Mesa Laboratories seller in Q1 2017 was Nine Ten Capital Management, an estimated $3.48M sold.
Based on aggregated 13F filings for Q1 2017.